Cargando…
Complex of the herpes simplex virus type 1 origin binding protein UL9 with DNA as a platform for the design of a new type of antiviral drugs
The herpes simplex virus type 1 origin-binding protein, OBP, is a DNA helicase encoded by the UL9 gene. The protein binds in a sequence-specific manner to the viral origins of replication, two OriS sites and one OriL site. In order to search for efficient inhibitors of the OBP activity, we have obta...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066892/ https://www.ncbi.nlm.nih.gov/pubmed/23879454 http://dx.doi.org/10.1080/07391102.2013.820110 |
_version_ | 1782322230493970432 |
---|---|
author | Bazhulina, N.P. Surovaya, A.N. Gursky, Y.G. Andronova, V.L. Moiseeva, E.D. Nikitin, A.M. Golovkin, M.V. Galegov, G.A. Grokhovsky, S.L. Gursky, G.V. |
author_facet | Bazhulina, N.P. Surovaya, A.N. Gursky, Y.G. Andronova, V.L. Moiseeva, E.D. Nikitin, A.M. Golovkin, M.V. Galegov, G.A. Grokhovsky, S.L. Gursky, G.V. |
author_sort | Bazhulina, N.P. |
collection | PubMed |
description | The herpes simplex virus type 1 origin-binding protein, OBP, is a DNA helicase encoded by the UL9 gene. The protein binds in a sequence-specific manner to the viral origins of replication, two OriS sites and one OriL site. In order to search for efficient inhibitors of the OBP activity, we have obtained a recombinant origin-binding protein expressed in Escherichia coli cells. The UL9 gene has been amplified by PCR and inserted into a modified plasmid pET14 between NdeI and KpnI sites. The recombinant protein binds to Box I and Box II sequences and possesses helicase and ATPase activities. In the presence of ATP and viral protein ICP8 (single-strand DNA-binding protein), the initiator protein induces unwinding of the minimal OriS duplex (≈80 bp). The protein also binds to a single-stranded DNA (OriS*) containing a stable Box I-Box III hairpin and an unstable AT-rich hairpin at the 3′-end. In the present work, new minor groove binding ligands have been synthesized which are capable to inhibit the development of virus-induced cytopathic effect in cultured Vero cells. Studies on binding of these compounds to DNA and synthetic oligonucleotides have been performed by fluorescence methods, gel mobility shift analysis and footprinting assays. Footprinting studies have revealed that Pt-bis-netropsin and related molecules exhibit preferences for binding to the AT-spacer in OriS. The drugs stabilize structure of the AT-rich region and inhibit the fluctuation opening of AT-base pairs which is a prerequisite to unwinding of DNA by OBP. Kinetics of ATP-dependent unwinding of OriS in the presence and absence of netropsin derivatives have been studied by measuring the efficiency of Forster resonance energy transfer (FRET) between fluorophores attached to 5′- and 3′- ends of an oligonucleotide in the minimal OriS duplex. The results are consistent with the suggestion that OBP is the DNA Holiday junction (HJ) binding helicase. The protein induces conformation changes (bending and partial melting) of OriS duplexes and stimulates HJ formation in the absence of ATP. The antiviral activity of bis-netropsins is coupled with their ability to inhibit the fluctuation opening of AT base pairs in the A + T cluster and their capacity to stabilize the structure of the AT-rich hairpin in the single-stranded oligonucleotide corresponding to the upper chain in the minimal duplex OriS. The antiviral activities of bis-netropsins in cell culture and their therapeutic effects on HSV1-infected laboratory animals have been studied. |
format | Online Article Text |
id | pubmed-4066892 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-40668922014-07-03 Complex of the herpes simplex virus type 1 origin binding protein UL9 with DNA as a platform for the design of a new type of antiviral drugs Bazhulina, N.P. Surovaya, A.N. Gursky, Y.G. Andronova, V.L. Moiseeva, E.D. Nikitin, A.M. Golovkin, M.V. Galegov, G.A. Grokhovsky, S.L. Gursky, G.V. J Biomol Struct Dyn Research Article The herpes simplex virus type 1 origin-binding protein, OBP, is a DNA helicase encoded by the UL9 gene. The protein binds in a sequence-specific manner to the viral origins of replication, two OriS sites and one OriL site. In order to search for efficient inhibitors of the OBP activity, we have obtained a recombinant origin-binding protein expressed in Escherichia coli cells. The UL9 gene has been amplified by PCR and inserted into a modified plasmid pET14 between NdeI and KpnI sites. The recombinant protein binds to Box I and Box II sequences and possesses helicase and ATPase activities. In the presence of ATP and viral protein ICP8 (single-strand DNA-binding protein), the initiator protein induces unwinding of the minimal OriS duplex (≈80 bp). The protein also binds to a single-stranded DNA (OriS*) containing a stable Box I-Box III hairpin and an unstable AT-rich hairpin at the 3′-end. In the present work, new minor groove binding ligands have been synthesized which are capable to inhibit the development of virus-induced cytopathic effect in cultured Vero cells. Studies on binding of these compounds to DNA and synthetic oligonucleotides have been performed by fluorescence methods, gel mobility shift analysis and footprinting assays. Footprinting studies have revealed that Pt-bis-netropsin and related molecules exhibit preferences for binding to the AT-spacer in OriS. The drugs stabilize structure of the AT-rich region and inhibit the fluctuation opening of AT-base pairs which is a prerequisite to unwinding of DNA by OBP. Kinetics of ATP-dependent unwinding of OriS in the presence and absence of netropsin derivatives have been studied by measuring the efficiency of Forster resonance energy transfer (FRET) between fluorophores attached to 5′- and 3′- ends of an oligonucleotide in the minimal OriS duplex. The results are consistent with the suggestion that OBP is the DNA Holiday junction (HJ) binding helicase. The protein induces conformation changes (bending and partial melting) of OriS duplexes and stimulates HJ formation in the absence of ATP. The antiviral activity of bis-netropsins is coupled with their ability to inhibit the fluctuation opening of AT base pairs in the A + T cluster and their capacity to stabilize the structure of the AT-rich hairpin in the single-stranded oligonucleotide corresponding to the upper chain in the minimal duplex OriS. The antiviral activities of bis-netropsins in cell culture and their therapeutic effects on HSV1-infected laboratory animals have been studied. Taylor & Francis 2013-07-24 2014-09 /pmc/articles/PMC4066892/ /pubmed/23879454 http://dx.doi.org/10.1080/07391102.2013.820110 Text en © 2013 The Author(s). Published by Taylor & Francis. http://www.informaworld.com/mpp/uploads/iopenaccess_tcs.pdf This is an open access article distributed under the Supplemental Terms and Conditions for iOpenAccess articles published in Taylor & Francis journals (http://www.informaworld.com/mpp/uploads/iopenaccess_tcs.pdf) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. This is an Open Access article. Non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly attributed, cited, and is not altered, transformed, or built upon in any way, is permitted. The moral rights of the named author(s) have been asserted. |
spellingShingle | Research Article Bazhulina, N.P. Surovaya, A.N. Gursky, Y.G. Andronova, V.L. Moiseeva, E.D. Nikitin, A.M. Golovkin, M.V. Galegov, G.A. Grokhovsky, S.L. Gursky, G.V. Complex of the herpes simplex virus type 1 origin binding protein UL9 with DNA as a platform for the design of a new type of antiviral drugs |
title | Complex of the herpes simplex virus type 1 origin binding protein UL9 with DNA as a platform for the design of a new type of antiviral drugs |
title_full | Complex of the herpes simplex virus type 1 origin binding protein UL9 with DNA as a platform for the design of a new type of antiviral drugs |
title_fullStr | Complex of the herpes simplex virus type 1 origin binding protein UL9 with DNA as a platform for the design of a new type of antiviral drugs |
title_full_unstemmed | Complex of the herpes simplex virus type 1 origin binding protein UL9 with DNA as a platform for the design of a new type of antiviral drugs |
title_short | Complex of the herpes simplex virus type 1 origin binding protein UL9 with DNA as a platform for the design of a new type of antiviral drugs |
title_sort | complex of the herpes simplex virus type 1 origin binding protein ul9 with dna as a platform for the design of a new type of antiviral drugs |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066892/ https://www.ncbi.nlm.nih.gov/pubmed/23879454 http://dx.doi.org/10.1080/07391102.2013.820110 |
work_keys_str_mv | AT bazhulinanp complexoftheherpessimplexvirustype1originbindingproteinul9withdnaasaplatformforthedesignofanewtypeofantiviraldrugs AT surovayaan complexoftheherpessimplexvirustype1originbindingproteinul9withdnaasaplatformforthedesignofanewtypeofantiviraldrugs AT gurskyyg complexoftheherpessimplexvirustype1originbindingproteinul9withdnaasaplatformforthedesignofanewtypeofantiviraldrugs AT andronovavl complexoftheherpessimplexvirustype1originbindingproteinul9withdnaasaplatformforthedesignofanewtypeofantiviraldrugs AT moiseevaed complexoftheherpessimplexvirustype1originbindingproteinul9withdnaasaplatformforthedesignofanewtypeofantiviraldrugs AT nikitinam complexoftheherpessimplexvirustype1originbindingproteinul9withdnaasaplatformforthedesignofanewtypeofantiviraldrugs AT golovkinmv complexoftheherpessimplexvirustype1originbindingproteinul9withdnaasaplatformforthedesignofanewtypeofantiviraldrugs AT galegovga complexoftheherpessimplexvirustype1originbindingproteinul9withdnaasaplatformforthedesignofanewtypeofantiviraldrugs AT grokhovskysl complexoftheherpessimplexvirustype1originbindingproteinul9withdnaasaplatformforthedesignofanewtypeofantiviraldrugs AT gurskygv complexoftheherpessimplexvirustype1originbindingproteinul9withdnaasaplatformforthedesignofanewtypeofantiviraldrugs |